• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Total Environ . Risk assessment of SARS-CoV-2 in Antarctic wildlife

tetano

Editor, Senior Moderator
Sci Total Environ


. 2020 Oct 29;143352.
doi: 10.1016/j.scitotenv.2020.143352. Online ahead of print.
Risk assessment of SARS-CoV-2 in Antarctic wildlife


Andr?s Barbosa[SUP] 1 [/SUP], Arvind Varsani[SUP] 2 [/SUP], Virginia Morandini[SUP] 3 [/SUP], Wray Grimaldi[SUP] 4 [/SUP], Ralph E T Vanstreels[SUP] 5 [/SUP], Julia I Diaz[SUP] 6 [/SUP], Thierry Boulinier[SUP] 7 [/SUP], Meagan Dewar[SUP] 8 [/SUP], Daniel Gonz?lez-Acu?a[SUP] 9 [/SUP], Rachael Gray[SUP] 10 [/SUP], Clive R McMahon[SUP] 11 [/SUP], Gary Miller[SUP] 12 [/SUP], Michelle Power[SUP] 13 [/SUP], Amandine Gamble[SUP] 14 [/SUP], Michelle Wille[SUP] 15 [/SUP]



Affiliations

Abstract

The coronavirus disease 2019 (COVID-19) pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This pathogen has spread rapidly across the world, causing high numbers of deaths and significant social and economic impacts. SARS-CoV-2 is a novel coronavirus with a suggested zoonotic origin with the potential for cross-species transmission among animals. Antarctica can be considered the only continent free of SARS-CoV-2. Therefore, concerns have been expressed regarding the potential human introduction of this virus to the continent through the activities of research or tourism to minimise the effects on human health, and the potential for virus transmission to Antarctic wildlife. We assess the reverse-zoonotic transmission risk to Antarctic wildlife by considering the available information on host susceptibility, dynamics of the infection in humans, and contact interactions between humans and Antarctic wildlife. The environmental conditions in Antarctica seem to be favourable for the virus stability. Indoor spaces such as those at research stations, research vessels or tourist cruise ships could allow for more transmission among humans and depending on their movements between different locations the virus could be spread across the continent. Among Antarctic wildlife previous in silico analyses suggested that cetaceans are at greater risk of infection whereas seals and birds appear to be at a low infection risk. However, caution needed until further research is carried out and consequently, the precautionary principle should be applied. Field researchers handling animals are identified as the human group posing the highest risk of transmission to animals while tourists and other personnel pose a significant risk only when in close proximity (< 5 m) to Antarctic fauna. We highlight measures to reduce the risk as well as identify of knowledge gaps related to this issue.

Keywords: Antarctica; COVID-19; Coronavirus; Mitigation measures; Reverse zoonoses; Transmission.
 
Back
Top Bottom